MHLW To Re-Examine Drug Sales System Information Sharing And Labeling
This article was originally published in PharmAsia News
The Pharmaceutical and Food Safety Bureau of Japan's Ministry of Health, Labor and Welfare will hold a forum on OTC drug labeling and information-sharing with consumers regarding risk categorization to re-examine the OTC sales system as part of a follow up to the New Drug Legislation passed in 2006. Risk categorization took effect in April 2007, and this April, a test registration system for pharmacists qualified to handle lower-class drugs (first-class is the highest risk category) will be enacted
You may also be interested in...
CV Defense, the second launch in the firm’s new immune-support line (without cannabidiol), is built around palmitoylethanolamide and other nutrients and botanicals to “optimize immune response.” CV Sciences touts the immunity range as complementary to its PlusCBD brand, which is in the process of rolling out dozens of new products in updated packaging.
Public Company Edition: Codiak, Kiromic, Aligos and Opthea have fallen below their initial public offering values, while Tarsus and Praxis are trading higher. Also, 5AM, MPM and Cormorant took biotech SPACs public and Evotec led recent non-IPO financings with a €250m private placement.
US, EU and Canadian authorities recently discussed their approaches to rolling reviews of CMC applications for coronavirus vaccines.